Clavicular Ascension Stack — Research Protocol Guide



12-Compound Ultimate Body Composition Research Stack

Clavicular Ascension Stack — Research Protocol Guide

The Clavicular Ascension Stack is QSC’s most comprehensive compound protocol — 12 synergistic research compounds addressing body composition, GH axis, collagen synthesis, metabolic rate, and androgen pathway from multiple mechanistic angles simultaneously.

Compound Manifest (12 Compounds)

# Compound Class Target Research Role
1 Retatrutide Triple GLP-1/GIP/GCGR agonist GLP-1R + GIPR + GCGR Metabolic axis — weight loss, insulin sensitisation, thermogenesis
2 HGH (Somatropin) Recombinant human growth hormone GH receptor (GHR) GH axis — IGF-1 upregulation, lipolysis, protein synthesis
3 IGF-1 LR3 Long-arginine-3 IGF-1 analogue IGF-1 receptor Anabolic axis — direct IGF-1R activation, muscle protein synthesis
4 CJC-1295 (No DAC) GHRH analogue GHRH receptor GH axis amplification — pulsatile GH output
5 Melanotan II MC1-5R non-selective agonist Melanocortin receptors Pigmentation, appetite, sexual function via MC1R-MC4R
6 GHK-Cu Copper tripeptide Fibroblast ECM pathways Collagen synthesis, ECM remodelling, anti-MMP activity
7 NAD+ Mitochondrial coenzyme SIRT1-3, PARP1-2 Mitochondrial biogenesis, DNA repair, metabolic regulation
8 Glutathione Master antioxidant tripeptide Glutathione peroxidase, ROS Antioxidant defence, hepatic detoxification
9 BPC-157 Gastric pentadecapeptide NO synthase, VEGF Tissue repair, angiogenesis, GI protection
10 TB-500 Thymosin Beta-4 fragment G-actin / actin dynamics Cell migration, cardiac repair, anti-inflammatory
11 Testosterone Cypionate 250mg Long-acting testosterone ester Androgen receptor (AR) HPG axis, anabolism, erythropoiesis, TRT pharmacology
12 Oxandrolone (Anavar) 25mg 17α-methylated DHT-derived oral AAS Androgen receptor (AR) Lean anabolic research, minimal aromatisation, oral AR agonism

Compound Stacking Logic

The stack addresses body composition from four simultaneous mechanistic directions: (1) Metabolic/appetite axis via Retatrutide triple agonism; (2) GH/IGF-1 axis via HGH + IGF-1 LR3 + CJC-1295 — three-level stimulation from exogenous GH, direct IGF-1R, and pituitary GHRH-R; (3) Androgen axis via Testosterone Cypionate + Anavar — AR agonism from injectable long-acting ester and oral DHT-derived compound; (4) Recovery/collagen/antioxidant support via BPC-157, TB-500, GHK-Cu, Glutathione, NAD+.

Frequently Asked Questions

What is the Clavicular Ascension Stack?
The Clavicular Ascension Stack is QSC’s 12-compound research protocol — the most comprehensive compound stack in the QSC catalog. It combines GLP-1 triple agonist (Retatrutide), GH axis (HGH + IGF-1 LR3 + CJC-1295), melanocortin (Melanotan II), androgen axis (Testosterone Cypionate + Oxandrolone), recovery (BPC-157 + TB-500), ECM support (GHK-Cu), and mitochondrial compounds (NAD+ + Glutathione).
How many vials are in the Clavicular Ascension Stack?
The Ascension Stack includes 110 lyophilized peptide vials plus 100 oral tablets (Oxandrolone 25mg). The vial kit covers all 10 injectable/peptide compounds in their full research quantities.
What makes this stack different from the Venus Protocol?
The Ascension Stack includes androgen-class compounds (Testosterone Cypionate + Anavar) and has a more aggressive body composition focus. The Venus Protocol is zero-androgen, targeting women’s health research. The Midas Protocol focuses on longevity pathway research.
Research Use Only: All QSC compounds are sold strictly for laboratory research purposes only. Not for human consumption, veterinary use, or any other application. Researchers are responsible for compliance with local regulations.
Peptides
Orals
Oils
Search
Contact